The mechanisms of anesthesia and the regulatory functions of nitric oxide (NO) 1 remain far from clear. Potential roles of anesthetic-protein interactions in anesthesia have become of increasing interest (1-5) as have the interactions of NO with proteins (6 -10). Volatile anesthetics occupy hydrophobic sites within protein without formation of covalent bonds with amino acid residues. In contrast, the reactions between NO and receptor sites in proteins that have been studied extensively involve covalent bond formation, as in metal nitrosyl and Snitrosothiol (-SNO) derivatives (7-10). Nitrosations (i.e. attack of protein residues by NOϩ) on exposure of proteins to NO with a suitable oxidant present are the only reactions of NO that have been discussed other than the binding of NO to metal sites. Evidence of NO occupying sites within proteins as an uncharged diatomic free radical by means of anesthetic-like noncovalent bonding has not been reported.The binding of volatile anesthetics to serum albumins and the effects of such binding on protein structure are considered in several recent reports. Specific, saturable binding of halothane and other anesthetics to bovine serum albumin and anesthetic-induced alterations in the structure or carrier function of this protein have been shown (11-16). The anesthetic nitrous oxide (NNO) was detected at sites within human serum albumin (HSA) (5). Infrared (IR) spectra of bound NNO molecules demonstrated sites of two types. The exposure of HSA to NNO enhanced absorbance in the S-H stretching region of the IR spectrum giving evidence of an NNO-induced change in protein conformation near Cys 34 (5). In 1992, NO was proposed to circulate in mammalian plasma primarily in association with serum albumin, due to formation of the S-nitrosothiol derivative (17). However, the similarities in the structure and physical properties of NNO and NO suggest the possibility that NO may also interact at some sites within albumin in the manner shown for NNO.IR evidence of NNO molecules at multiple sites within hemoglobin, myoglobin, and cytochrome c oxidase (CcO) has also been obtained (5,18). NNO neither serves as a ligand to heme iron nor reacts with thiols. The ability of NNO to alter hemeprotein structure and function was shown by shifts in the IR spectra of cysteine thiols of HbA (5) and by partial and reversible inhibitions of CcO (18). The well established ability of NO to ligate to heme iron in HbA, Mb, and CcO, and to copper B in CcO (19,20), led to the assumption of metal binding in proposed mechanisms for physiologically important reactions of NO with hemeproteins. Reactions of NO with HbA that result in S-nitrosothiol derivative formation have also received much attention (8). However, alternative mechanisms whereby NO alters hemeprotein structure and function by noncovalent anesthetic-like bonding to sites that involve neither metal nor cysteine sulfur remain unexplored.Much interest in possible physiological roles of carbon monoxide (CO), including a messenger role in the nervous syst...